*Corresponding author:
Zhenwu Lin, Senior Research Scientist, Department of Radiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, USAReceived: January 17, 2018; Published: January 31, 2018
DOI: 10.26717/BJSTR.2018.02.000713
To view the Full Article Peer-reviewed Article PDF
Inflammatory bowel disease (IBD) is an auto-immune condition characterized by chronic gastrointestinal inflammation. The incidence of pediatric IBD, particularly the early onset disease subtypes, has been increasing internationally. In contrast to later-onset IBD, recent literature indicates that early-onset (between 3 - 5 years) and very early-onset (between 0 - 2 years) patients present with a more severe and aggressive disease. A comprehensive review of the literature indicates that the gut microbiome, which is heavily influenced in the early life, is reduced in IBD patients and hence plays a role in regulating gastrointestinal homeostasis. While many genes have been confirmed to be associated with IBD, only a portion of those genes have been shown to cause pediatric IBD.
The IL-10/STAT3 pathway is a well-studied gene pathway as is, involved in maintaining immune homeostasis in both acute and chronic inflammation. Accumulating evidence indicates that IL-10/STAT3 pathway is a key player in pediatric IBD. New mutations identified within the IL-10 pathway have been shown to disrupt immune homeostasis and cause gastrointestinal inflammation. Furthermore, significant epistatic interactions have been demonstrated between different single-nucleotide polymorphisms of IL-10 genes suggesting that understanding gene interactions within the IL-10//STAT3 pathway may be key to understanding more about IBD pathogenesis. Heme oxygenase 1 (HO-1) is speculated to be regulated by the IL-10/STAT3 pathway and hence involved in pediatric IBD formation. This review aims to provide an overview of pediatric IBD and discuss the role of the gut microbiome, IL-10/STAT3 pathway, and HO-1 gene in modulating immune homeostasis in IBD pathogenesis.
Key words: Inflammatory bowel disease; Crohn’s disease; Ulcerative colitis; Pediatric; Early onset; Very early-onset; IL-10, STAT3; HO-1
Abbreviations: IBD: Inflammatory Bowel Disease; UC: Ulcerative Colitis; CD: Crohn’s Disease; NVDW: Neutrophil Volume Distribution width; PCDAI: Pediatric Crohn’s Disease Activity Index;
Abstract| Introduction| Conclusion| Acknowledgement| References|
International Association of Landscape Archaeology, Czech Glass Society, Czech Republic
Department of Chemistry, Semenov Institute of Chemical Physics, USSR Academy of Sciences, Moscow, Russia
Pharmaco-kinetics, dynamics and Drug Metabolism, Touro College of Pharmacy, USA
Professor of Nuclear Medicine, Faculty of Medicine and Surgery, University of Milan, Milan, Italy
Associate Professor at Department of Breast and Thyorid Surgey, Chongqing General Hospital, China